rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptide
ARHGDIG
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN937278
Aperçu rapide pour rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptide (ABIN937278)
Antigène
ARHGDIG
(rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- DEAVPEYRAP GRKSLLEIRQ LDPDDRSLAK YKRVLLGPLP PAVDPSLPN
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGDIG antibody,
Alternative Names: ARHGDIG control peptide, ARHGDIG antibody Blocking Peptide, Anti-ARHGDIG Blocking Peptide, Rho Gdp Dissociation Inhibitor Blocking Peptide, Gdi Gamma Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- ARHGDIG (rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
-
Sujet
- ARHGDIG is highly expressed in the entire brain, with regional variations. The mRNA is also present at high levels in kidney and pancreas and at moderate levels in spinal cord, stomach, and pituitary gland. ARHGDIG is mapped to chromosome band 16p13.3 which is rich in deletion mutants of genes involved in several human diseases, notably polycystic kidney disease, alpha-thalassemia, tuberous sclerosis, mental retardation, and cancer.
-
Poids moléculaire
- 25 kDa
Antigène
-
Vous êtes ici:
